Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) SHH
19.61
+0.08(+0.41%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
19.61
+0.08(+0.41%)
Currency In CNY
| Market Cap | 11.47B |
| Enterprise Value | 10.54B |
| P/E Ratio | 86.41 |
| PEG Ratio | 3.28 |
| Price/Sales Ratio | 6.28 |
| Price/Book Ratio | 2.56 |
| Enterprise/Revenue | 5.2 |
| Enterprise/EBITDA | 24.83 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.08 |
| Operating Margin | 0.12 |
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
| Revenue | 1.45B |
| Revenue/Share | 2.93 |
| Gross Profit | 1.02B |
| EBITDA | 335.87M |
| Net Income | 113.83M |
| Diluted EPS | 0.25 |
| Total Cash | 1.73B |
| Total Cash/Share | 3.58 |
| Total Debt | 52.83M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 1.88 |
| Book Value Per Share | 7.77 |
| 52-Week Change | -17.85 |
| 52-Week High | 32.99 |
| 52-Week Low | 19.27 |
| Moving Average 50 Days | 26.08 |
| Moving Average 200 Days | 26.23 |
| Average Volume | 14.95M |
| Shares Outstanding | 455.1M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 16983:10000 |
| Last Split Date | January 24, 2007 |